Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.30
-0.53-3.34%
Last update: Oct 22, 9:19 AM
$15.30
-0.53-3.34%
Summit Therapeutics Inc (SMMT) Stock Price, Quote, News & History
SMMTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.
Other companies in Summit Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Summit Therapeutics has a consensus price target of $31.86.
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $15.3014 last updated October 22, 2026 at 9:19 AM EDT.
There are no upcoming dividends for Summit Therapeutics.
Summit Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Summit Therapeutics.
Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
